New Study suggests MDMA can reduce symptoms of PTSD
A new study sponsored by the Multidisciplinary Association for Psychedelic Studies (MAPS) has found that MDMA, also known as Ecstasy or Molly, may be effective in reducing symptoms of post-traumatic stress disorder (PTSD). The study involved 104 people with PTSD who were randomly assigned to take either MDMA or a placebo pill over three sessions, one month apart.
The results of the study, published in Nature Medicine, showed that 86% of participants who took MDMA showed improvement in PTSD symptoms, compared to 69% of those who took a placebo. This finding suggests that MDMA-assisted therapy could be a promising treatment option for individuals suffering from PTSD.
However, it is important to note that the use of MDMA does come with some side effects. Participants reported experiencing nausea, sweating, muscle tightness, and a decreased appetite. These side effects, although generally considered mild, should be taken into consideration when considering MDMA as a potential treatment for PTSD.
Despite these potential benefits, medical experts have cautioned that more research is needed on the efficacy and risks of psychedelics. The American Psychiatric Association has not endorsed the use of psychedelics in treatment, and the U.S. Food and Drug Administration (FDA) is yet to approve MDMA for therapeutic use in treating PTSD.
However, there seems to be growing momentum for the use of psychedelic substances in mental health treatments. In July, Australia became the first country to allow psychiatrists to prescribe certain psychedelic substances, including MDMA, to patients with depression or PTSD. Moreover, the FDA designated psilocybin, the psychoactive ingredient in psychedelic mushrooms, as a “breakthrough therapy” in 2018.
According to MAPS founder and president Rick Doblin, MDMA-assisted therapy for PTSD is on track to be considered for approval by the FDA by 2024. This could mark a significant turning point in the treatment of PTSD, offering hope to those who have not responded well to traditional therapies.
While the results of this study are promising, it is important to approach them with caution. More research is needed to fully understand the potential benefits and risks of psychedelics in treating mental health disorders. Nonetheless, the growing interest and support for these substances suggest that they may have a place in the future of mental health treatments.
Internet geek. Wannabe bacon enthusiast. Web trailblazer. Music maven. Entrepreneur. Pop culture fan.